AM Biotechnologies, LLC (MEI Technologies Investment)

AM Biotechnologies offers proprietary technologies and customer-responsive research support to the biotech market. AM Biotechnologies has international rights to thiophosphoramidite reagent production and bead-based phosphordithioate aptamer (thioaptamer) discovery and production. Thioaptamers are short strands of laboratory-modified DNA or RNA that can be used in many of the same applications as antibodies (research, diagnostics and therapeutics) while offering unique advantages. Areas of research and product development include Thiophosphoramidite Production (dA, dC, dT, and dG), Thioaptamer Discovery and Synthesis, Nucleic Acid Chemistry, and Scientific and Biotechnology Research Support. For additional information on thioaptamers and AM Biotechnologies, visit www.thioaptamer.com.

Point of Contact
Management: Mark Shumbera, 281-794-2333

< back